Alcohol Use Disorder (AUD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

 Alcohol Use Disorder (AUD) is a pathological condition characterized by persistent and excessive alcohol consumption, leading to a diminished ability to limit or abstain from alcohol use despite adverse consequences in one's social, occupational, or medical domain. The disease is characterized by several key symptoms, including: 1. Craving - an intense urge to consume alcohol 2. Loss of control - an inability to cease alcohol consumption once initiated 3. Negative emotional state - feelings of anxiety and irritability when abstaining from alcohol. Several factors increase the chances of developing an alcohol use disorder, such as Family history of substance abuse and alcohol use disorder, Accessibility of alcohol, Excessive alcohol consumption, Binge drinking, Permissive cultural attitudes towards alcohol, Childhood abuse, Childhood conduct or mood disorders, Co-occurring mental health conditions such as depression and PTSD, Impulsivity. Diagnosis of AUD is made through a comprehensive evaluation and assessment of symptoms, as outlined in the Diagnostic and Statistical Manual of Mental Disorders. The severity of the disorder is determined based on the number of criteria met and can range from mild (2-3 criteria), to moderate (4-5 criteria) to severe (6 or more criteria). The U.S. Food and Drug Administration approved three drugs for managing AUD, including naltrexone, acamprosate, and disulfiram, which aid in reducing alcohol consumption and preventing relapse.

·       According to a national survey in the USA, 14.1 million adults ages 18 and older (5.6% of this age group) had alcohol use disorder (AUD).

Thelansis’s “Alcohol Use Disorder (AUD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Alcohol Use Disorder (AUD) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Alcohol Use Disorder (AUD) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Alcohol Use Disorder (AUD) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Alcohol Use Disorder (AUD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032